Ponatinib (AP24534)

Catalog No.S1490

Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.

Price Stock Quantity  
USD 100 In stock
USD 110 In stock
USD 370 In stock
USD 970 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Ponatinib (AP24534) Chemical Structure

Ponatinib (AP24534) Chemical Structure
Molecular Weight: 532.56

Validation & Quality Control

Customer Product Validation(2)

Quality Control & MSDS

Related Compound Libraries

Bcr-Abl Inhibitors with Unique Features

  • Selective Bcr-Abl Inhibitor

    Nilotinib (AMN-107) Bcr-Abl-selective, IC50<30 nM.

  • Most Potent Bcr-Abl Inhibitor

    GZD824 Bcr-Abl(WT), IC50=0.34 nM; Bcr-Abl(T315I), IC50=0.68 nM.

  • FDA-approved Bcr-Abl Inhibitor

    Dasatinib Approved by FDA for CML and Ph+ ALL.

  • Newest Bcr-Abl Inhibitor

    GZD824 Orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

Product Information

  • Compare Bcr-Abl Inhibitors
    Compare Bcr-Abl Products
  • Research Area
  • Ponatinib (AP24534) Mechanism

Product Description

Biological Activity

Description Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.
Targets Abl [1]
(Cell-free assay)
PDGFRα [1]
(Cell-free assay)
VEGFR2 [1]
(Cell-free assay)
FGFR1 [1]
(Cell-free assay)

 View  More

IC50 0.37 nM 1.1 nM 1.5 nM 2.2 nM
In vitro AP24534 potently inhibits native Abl, AblT315I, and other clinically important Abl kinase domain mutants with IC50 of 0.30 nM–2 nM. AP24534 doesn't inhibit Aurora kinase family members, nor does it inhibit insulin receptor or CDK2/cyclin E. AP24534 inhibits proliferation of Ba/F3 cells expressing Bcr-Abl with IC50 of 0.5 nM, as well as Ba/F3 cells expressing a range of Bcr-Abl mutants with IC50 of 0.5 nM–36 nM. The inhibition of proliferation by AP24534 is correlated with induction of apoptosis. [1-2] In leukemic cell lines containing activated forms of FLT3, KIT, FGFR1, and PDGFRα receptors, AP24534 potently inhibits receptor phosphorylation and cellular proliferation with IC50 of 0.3 nM to 20 nM. In MV4-11 (FLT3-ITD(+/+)) but not RS4;11 (FLT3-ITD(–/–)) AML cells, AP24534 inhibits FLT3 signaling and induced apoptosis at less than 10 nM. AP24534 inhibits viability of primary leukemic blasts from a FLT3-ITD positive AML patient with IC50 of 4 nM but not those from patients with AML expressing native FLT3. [3] In Ba/F3 cells engineered to express activated FGFR1-4, AP24534 potently inhibits FGFR-mediated signaling and viability with IC50 lower than 40 nM. In cell lines representing multiple tumor types (endometrial, bladder, gastric, breast, lung, and colon), and containing FGFRs dysregulated by a variety of mechanisms, AP24534 inhibits FGFR-mediated signaling with IC50 less than 40 nM and inhibits cell growth with IC50 of 7 nM–181 nM. [4]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
EoL-1-cellNVzIU2hKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHLTUpVKSzVyPUCuNFAxODByMEO1PUDPxE1?NVnFNZJiW0GQR1XS
MV-4-11NITZNmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlnETWM2OD1yLkCwNFA6PTZizszNNV3qfYl3W0GQR1XS
MEG-01NEDhUG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUSwNVRlUUN3ME2wMlAxODF{ODFOwG0>M3H1ZXNCVkeHUh?=
LAMA-84MkXTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkXMTWM2OD1yLkCwNFE3PSEQvF2=M1WxfXNCVkeHUh?=
CGTH-W-1MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUjwcWp{UUN3ME2wMlAxOTZ7IN88US=>NIHN[nlUSU6JRWK=
KASUMI-1MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX3JR|UxRTBwMECyNVch|ryPM1Lic3NCVkeHUh?=
BE-13NWrZPHRTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlG4TWM2OD1yLkCwNlU6KM7:TR?=M1T1cXNCVkeHUh?=
CTV-1M1zYNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFnoNHpKSzVyPUCuNFA2OjFizszNNV7MVZB3W0GQR1XS
NKM-1NULte|R3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3HjbGlEPTB;MD6wNFY2PSEQvF2=NI\BUG9USU6JRWK=
MONO-MAC-6NFnEOHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWfKc5o6UUN3ME2wMlAxQDN5IN88US=>MmOyV2FPT0WU
A204M2joUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTBwMEGyNVgh|ryPMoDwV2FPT0WU
GDM-1MmD5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4LUcmlEPTB;MD6wNVg{OyEQvF2=M2C0NHNCVkeHUh?=
AN3-CAMoL2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWrJR|UxRTBwMEG4O|Mh|ryPMXjTRW5ITVJ?
BL-70NID3VpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVXJR|UxRTBwMEKxPVkh|ryPMUTTRW5ITVJ?
DaudiM3ewSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2rFOGlEPTB;MD6wNlU{PyEQvF2=MVHTRW5ITVJ?
KU812NIfycZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{P0ZWlEPTB;MD6wNlg1QCEQvF2=NHvXUodUSU6JRWK=
KG-1MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkjhTWM2OD1yLkCzNlk1KM7:TR?=MYLTRW5ITVJ?
DOHH-2MoDhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2jWNWlEPTB;MD6wOFgxOyEQvF2=Ml3OV2FPT0WU
HuO9MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmjwTWM2OD1yLkC1OFQ5KM7:TR?=NXq5dnluW0GQR1XS
EB2NHHDZoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYf5emE2UUN3ME2wMlA2PTd4IN88US=>NVXhcWF7W0GQR1XS
G-402M2jXPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWm3eI5RUUN3ME2wMlA3OzRzIN88US=>NWW2XIpSW0GQR1XS
SU-DHL-1NGHLSlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXLJR|UxRTBwME[zO|kh|ryPMoX4V2FPT0WU
NCI-H719NEnG[ZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4joUGlEPTB;MD6wO|g5QCEQvF2=NYTXR|luW0GQR1XS
MLMANUCybXZOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWLJR|UxRTBwMEmwOkDPxE1?M4nYRXNCVkeHUh?=
KM12MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUnJR|UxRTBwMEm3N|ch|ryPNGDo[5dUSU6JRWK=
SUP-T1NWiyd3pQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkLSTWM2OD1yLkC5PVgzKM7:TR?=MWPTRW5ITVJ?
MZ1-PCMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU\RVlFSUUN3ME2wMlEyOzN4IN88US=>M3P0fHNCVkeHUh?=
MFE-296NV\RUopsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M17ONWlEPTB;MD6xNVg{QSEQvF2=NFXOfJpUSU6JRWK=
ALL-POM3LCOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{XqeWlEPTB;MD6xNlQ1OyEQvF2=NHTsUm1USU6JRWK=
GB-1NEnvZVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{HQXGlEPTB;MD6xNlUyOiEQvF2=NXHXR3pRW0GQR1XS
SIG-M5M4HoRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTBwMUOzO{DPxE1?NWTOTHh7W0GQR1XS
P30-OHKNUnIZo91T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXLKb3pxUUN3ME2wMlE2Pjd{IN88US=>MUDTRW5ITVJ?
NCI-H716MlPLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGHyT3RKSzVyPUCuNVYzPjZizszNMnfLV2FPT0WU
MPP-89MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkHsTWM2OD1yLkG2PVM{KM7:TR?=NGjnWplUSU6JRWK=
SF126NGi0fHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnzQTWM2OD1yLkG3NFY{KM7:TR?=M1vwPXNCVkeHUh?=
CTB-1MnjCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV3JR|UxRTBwMUezNVYh|ryPMVfTRW5ITVJ?
CA46MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2HtRWlEPTB;MD6xO|Q5QSEQvF2=M2TD[XNCVkeHUh?=
NCI-H520NF3pS4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXvEWm1[UUN3ME2wMlE4PzN{IN88US=>NHXBOpJUSU6JRWK=
CAL-85-1MkX6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXq5c4h6UUN3ME2wMlE4QTJ5IN88US=>M{PhbXNCVkeHUh?=
NCI-H2342MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFT6N45KSzVyPUCuNVg2PzdizszNM3vvTXNCVkeHUh?=
697MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXzpWlhWUUN3ME2wMlE5QDdzIN88US=>NWH0c5l[W0GQR1XS
NYMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVHacJVOUUN3ME2wMlE6Ojh5IN88US=>NUSwNVA{W0GQR1XS
T98GMYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NILNWoFKSzVyPUCuNVk{OThizszNM3rhUnNCVkeHUh?=
NCI-H1703M3y0WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYntR2J4UUN3ME2wMlE6PjF3IN88US=>NUjGeoxWW0GQR1XS
NCI-H2087MlO1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVzJR|UxRTBwMkC0N|kh|ryPNFzRXHlUSU6JRWK=
PF-382MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkTaTWM2OD1yLkKwPFc{KM7:TR?=NUPl[2l6W0GQR1XS
HCT-116M2S1O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW[x[4xbUUN3ME2wMlIyODZ7IN88US=>NIG3[HhUSU6JRWK=
CAKI-1NFyzSnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXXJR|UxRTBwMkG2OlYh|ryPNVX3VFJDW0GQR1XS
CCF-STTG1NYq2WpoxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUjNUYFJUUN3ME2wMlIzPDd3IN88US=>MmriV2FPT0WU
D-392MGMlPlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYm4eVdOUUN3ME2wMlI{OTd5IN88US=>MXXTRW5ITVJ?
RT-112NGHTS5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXfJR|UxRTBwMkO3PVUh|ryPMmDWV2FPT0WU
MES-SAMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWHJR|UxRTBwMkSxPFch|ryPM2T0O3NCVkeHUh?=
LC-2-adM{\KZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXfJR|UxRTBwMkSyOlUh|ryPMl;IV2FPT0WU
NOS-1NHPLbmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{[4V2lEPTB;MD6yOFM3PyEQvF2=MlftV2FPT0WU
NALM-6MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX3JR|UxRTBwMkW1OFMh|ryPMo\xV2FPT0WU
TE-15NXW2OWgzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGXKOJpKSzVyPUCuNlYxQTFizszNNWjsbFFuW0GQR1XS
786-0MoPsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlP4TWM2OD1yLkK2NlI5KM7:TR?=Mof0V2FPT0WU
IST-MES1NWjadoQ6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2XPU2lEPTB;MD6yOlgzQSEQvF2=MXPTRW5ITVJ?
KYSE-180MkXNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{LFRmlEPTB;MD6yOlg6OSEQvF2=MnvDV2FPT0WU
YTMYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIXYWJlKSzVyPUCuNlY6PzRizszNNUmyZ4FFW0GQR1XS
A427NHHHdYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWXUOWlUUUN3ME2wMlI4OjZ2IN88US=>M4\WS3NCVkeHUh?=
KYSE-450M2TCdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NE\GdmhKSzVyPUCuNlc{OjlizszNMX;TRW5ITVJ?
HuH-7Ml7oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWPJR|UxRTBwMke3OlMh|ryPM2HzSXNCVkeHUh?=
CAS-1MmDYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYjJR|UxRTBwMkizNFMh|ryPNYDM[nI{W0GQR1XS
KURAMOCHIMnexS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1vQRWlEPTB;MD6yPFQyQSEQvF2=M17OdHNCVkeHUh?=
ACHNMn6zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXrJR|UxRTBwMkmzNlMh|ryPNWjLNXJ4W0GQR1XS
HGC-27MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGfkZ2dKSzVyPUCuNlk{PTNizszNMVrTRW5ITVJ?
A172Mn;sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUXJR|UxRTBwMkm1O|ch|ryPNIPkVY1USU6JRWK=
SNU-449MkD3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWXJR|UxRTBwMkm5OlQh|ryPM{\FOHNCVkeHUh?=
SW982MnHkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVnJR|UxRTBwMkm5O|gh|ryPNWnBcYszW0GQR1XS
EFO-21MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NELMUVJKSzVyPUCuN|A1OTFizszNMXvTRW5ITVJ?
NCI-H2030MkXjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVPJR|UxRTBwM{GxOlQh|ryPNIj1dZpUSU6JRWK=
HT-144MljTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXzJR|UxRTBwM{GyPEDPxE1?MnT4V2FPT0WU
MFE-280MoTHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFj2b4xKSzVyPUCuN|E1PTNizszNM4rLbXNCVkeHUh?=
SK-LU-1MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2Hvd2lEPTB;MD6zNVQ3PiEQvF2=MV;TRW5ITVJ?
NCI-H2052NFHqOnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1PifWlEPTB;MD6zNVQ5PCEQvF2=MnnJV2FPT0WU
SK-HEP-1NVq3[mRLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{fnO2lEPTB;MD6zN|M3QCEQvF2=NEnQVmtUSU6JRWK=
QIMR-WILMXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoHQTWM2OD1yLkOzOFI1KM7:TR?=MX3TRW5ITVJ?
A2780MkfHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmLJTWM2OD1yLkO0N|A1KM7:TR?=MYjTRW5ITVJ?
ACNNIHBOmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWLaU3Q2UUN3ME2wMlM1QDd|IN88US=>M{DufHNCVkeHUh?=
BxPC-3NF\4W5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWLJR|UxRTBwM{S5PFkh|ryPMnLUV2FPT0WU
BCPAPNY[zUmlVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYr4SHJbUUN3ME2wMlM3ODBzIN88US=>M{fGO3NCVkeHUh?=
HOP-62M2DwPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUTrOXBkUUN3ME2wMlM3OTB4IN88US=>Ml3FV2FPT0WU
SW1710NIDWVJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2PJ[GlEPTB;MD6zOlQ2PSEQvF2=MnHTV2FPT0WU
OPM-2M{HTW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWLJR|UxRTBwM{[0O|Mh|ryPNYXaVVJjW0GQR1XS
DBTRG-05MGNVPB[FJKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2rSOmlEPTB;MD6zPFA2PCEQvF2=M2HWfHNCVkeHUh?=
SK-MEL-24MnTPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3zqUWlEPTB;MD6zPVc6OSEQvF2=M4DBO3NCVkeHUh?=
8305CM3vTbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEDET2JKSzVyPUCuN|k4QTNizszNNXPiemNZW0GQR1XS
OVCAR-4MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTBwNEG1PFYh|ryPNXntWGk3W0GQR1XS
HLENHXh[XNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4LoWGlEPTB;MD60NVg3KM7:TR?=NGnQ[oRUSU6JRWK=
NCI-H747MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXzJR|UxRTBwNEKxN|ch|ryPNWLpSlJTW0GQR1XS
SW780M3fuPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWO5dmVKUUN3ME2wMlQzOzR4IN88US=>MVfTRW5ITVJ?
KYSE-150M4frXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYLJR|UxRTBwNEK0NVUh|ryPMWrTRW5ITVJ?
H4M3noUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2GwcWlEPTB;MD60NlQ2OSEQvF2=M375SnNCVkeHUh?=
SW1088NIS5SndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoX2TWM2OD1yLkS0N|kh|ryPMWrTRW5ITVJ?
SF268MmP4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHizcWZKSzVyPUCuOFQ5PiEQvF2=M3;FbXNCVkeHUh?=
RT4NH\TUlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{XQN2lEPTB;MD60OVEyOSEQvF2=M1noW3NCVkeHUh?=
NCI-H522NWPSe|JNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4O3ZmlEPTB;MD60OVI4KM7:TR?=NFv1bYNUSU6JRWK=
LCLC-97TM1M2HXXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX;3S|hHUUN3ME2wMlQ3OTl3IN88US=>M1HI[nNCVkeHUh?=
CAL-39NH33VHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXLrUYFkUUN3ME2wMlQ3PTF7IN88US=>NELqdGhUSU6JRWK=
CAL-120NGrzb2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4X5XmlEPTB;MD60O|Y1OyEQvF2=NXzKPVFZW0GQR1XS
ESS-1MmHSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3:yWWlEPTB;MD60O|gzOSEQvF2=MX\TRW5ITVJ?
KARPAS-45NGLPXmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXLq[JBzUUN3ME2wMlQ5QTN|IN88US=>NYLnRlBSW0GQR1XS
DU-4475MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{fxWGlEPTB;MD60PVUyOSEQvF2=M4nwenNCVkeHUh?=
VMRC-RCZNYjJSIplT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3izdGlEPTB;MD60PVkxPCEQvF2=MWXTRW5ITVJ?
HOSNUnmR2hTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{jifmlEPTB;MD61NFM3PSEQvF2=NFr0W4lUSU6JRWK=
MOLT-16NF;C[mFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFv2SIlKSzVyPUCuOVE5ODhizszNNVvFbWVQW0GQR1XS
RPMI-6666NFfUNZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGHuZmNKSzVyPUCuOVIyOzVizszNMoPEV2FPT0WU
K052MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlfCTWM2OD1yLkWyNVQh|ryPMV\TRW5ITVJ?
EHEBNGX5b4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGX3fZFKSzVyPUCuOVIyQDJizszNNX7McmQyW0GQR1XS
MFH-inoMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEjqOlFKSzVyPUCuOVI{PTFizszNMV3TRW5ITVJ?
A4-FukMWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXnJR|UxRTBwNUK1Nlgh|ryPMX3TRW5ITVJ?
SW1417NF\rRYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWXJR|UxRTBwNUK3PFEh|ryPMYLTRW5ITVJ?
DoTc2-4510NWLjUlhVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXjJR|UxRTBwNUS5OVgh|ryPMV\TRW5ITVJ?
TE-12M1\vUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NImyNZJKSzVyPUCuOVU4OzVizszNMYfTRW5ITVJ?
8-MG-BANXfSRWV7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVnp[|ZZUUN3ME2wMlU3ODV4IN88US=>Mn;xV2FPT0WU
ECC12MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFzSU3JKSzVyPUCuOVY2PThizszNMlrjV2FPT0WU
CHL-1MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkHNTWM2OD1yLkW3OFY{KM7:TR?=M3TQcXNCVkeHUh?=
LCLC-103HM1r2W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4ftPWlEPTB;MD61PFM1PCEQvF2=NGDtU45USU6JRWK=
OS-RC-2NGnLfXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXnJR|UxRTBwNUizO|kh|ryPM1rsSHNCVkeHUh?=
RO82-W-1M2nXeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4OxfWlEPTB;MD61PVYyPSEQvF2=NFixVXlUSU6JRWK=
A3-KAWNYDoPYYzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFzMVnZKSzVyPUCuOlE1PjdizszNNIDEOIVUSU6JRWK=
NCCITMlPzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3\KZ2lEPTB;MD62NVcyPSEQvF2=M3LUd3NCVkeHUh?=
IST-SL2Mn7iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTBwNkK1NlIh|ryPNGqzOmZUSU6JRWK=
GI-ME-NM3naZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUXDcZFOUUN3ME2wMlY{ODZ7IN88US=>Ml7CV2FPT0WU
ES6M2TPe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXvJR|UxRTBwNkOyPVUh|ryPMkG5V2FPT0WU
BL-41MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXHVZlBbUUN3ME2wMlY{OzV{IN88US=>NH33R3RUSU6JRWK=
Ca-SkiMni3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml\WTWM2OD1yLk[0PFEh|ryPNFq3fpBUSU6JRWK=
HOP-92NWroN406T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkHHTWM2OD1yLk[1OlczKM7:TR?=NEn0flRUSU6JRWK=
SK-LMS-1MnS4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmDsTWM2OD1yLk[2OFch|ryPNY\QdWRQW0GQR1XS
EW-13M4jsRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MknjTWM2OD1yLk[2O|c6KM7:TR?=M17rR3NCVkeHUh?=
647-VNHftOZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUDmbI9uUUN3ME2wMlY5OTR6IN88US=>NFrFflNUSU6JRWK=
JiyoyeP-2003M2fJPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYLPXFRHUUN3ME2wMlY6PzN6IN88US=>NEHqXndUSU6JRWK=
WSU-NHLM3j3VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVzJR|UxRTBwN{C4PFch|ryPNWe0Z|V3W0GQR1XS
U-698-MNFTlXZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTBwN{GwOlMh|ryPNV7ZUGhxW0GQR1XS
HC-1NV:1Uo01T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUPJR|UxRTBwN{K0NFUh|ryPMUXTRW5ITVJ?
8505CNYL1ZoViT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUDJR|UxRTBwN{K3OFEh|ryPM{T5eHNCVkeHUh?=
HUTU-80M4q2Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1fWbmlEPTB;MD63N|M1QSEQvF2=NXnvNXBUW0GQR1XS
LB1047-RCCNFLDPHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlvZTWM2OD1yLkezOVM5KM7:TR?=M3TYOHNCVkeHUh?=
GAMGMkm2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX;JR|UxRTBwN{O2OVMh|ryPNXzHWYR3W0GQR1XS
CAL-12TM{DkSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn7sTWM2OD1yLkezPFc4KM7:TR?=MlLmV2FPT0WU
NCI-SNU-1NFXNTIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M323XGlEPTB;MD63O|I4QCEQvF2=NG[xUZpUSU6JRWK=
HTC-C3MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3LvXGlEPTB;MD63O|Q2OSEQvF2=MnLKV2FPT0WU
HPAF-IINXnvXINuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3XtZmlEPTB;MD63O|UxOSEQvF2=NV\iZ|hzW0GQR1XS
KGNM33jc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYnJR|UxRTBwN{iwPFEh|ryPM{W2N3NCVkeHUh?=
EFO-27NVnJc|JoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHPlbXlKSzVyPUCuO|g4OzNizszNMknPV2FPT0WU
MEL-HONVTjdmxDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHPrZZpKSzVyPUCuO|k1PDlizszNM2H5O3NCVkeHUh?=
KYSE-270MoPlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoWwTWM2OD1yLkiwOVI6KM7:TR?=NX[xfWRWW0GQR1XS
NCI-H1755NUXTNWlFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4LZZmlEPTB;MD64NFcyPCEQvF2=NIjTdIlUSU6JRWK=
MFM-223NUKzXmhOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFnhZ5hKSzVyPUCuPFE1ODdizszNMWDTRW5ITVJ?
G-361MlXXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWPLcnZrUUN3ME2wMlgyQDl5IN88US=>M2Tpe3NCVkeHUh?=
ETK-1M{TESGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVXWNZBIUUN3ME2wMlgzPDRzIN88US=>M3L3SnNCVkeHUh?=
LU-99ANH\GVopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYHuVYM2UUN3ME2wMlg1PzBzIN88US=>MknJV2FPT0WU
IST-MEL1MoThS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXPs[ZFVUUN3ME2wMlg2PzN{IN88US=>MWjTRW5ITVJ?
L-540M{\MSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXn2TlNQUUN3ME2wMlg2QDBzIN88US=>NXntSHF3W0GQR1XS
U-2-OSMl;GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVnvdoVnUUN3ME2wMlg2QDR4IN88US=>Ml3KV2FPT0WU
HT-1376NGXRWmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmfaTWM2OD1yLki2NFUyKM7:TR?=NWnxUYxGW0GQR1XS
COLO-680NNInFNVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4GzRWlEPTB;MD64O|k{OyEQvF2=NUDpdmppW0GQR1XS
NCI-H1581M2rtfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoTSTWM2OD1yLki5Nlk4KM7:TR?=NWfWWVFpW0GQR1XS
HuCCT1MnT4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYL5N5JiUUN3ME2wMlg6PTR6IN88US=>Moj3V2FPT0WU
BB30-HNCMkPQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWP4WoxyUUN3ME2wMlkzPDZ7IN88US=>NYfRUFBWW0GQR1XS
NCI-H2347NWn3NVJnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUjJR|UxRTBwOUOyPVIh|ryPNEO1[YlUSU6JRWK=
G-401NH;OT5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1PTT2lEPTB;MD65N|Y6PSEQvF2=MoDRV2FPT0WU
NCI-H358MkHYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWPJR|UxRTBwOUWwNVQh|ryPNWHkbFd7W0GQR1XS
HCC1395M4T6c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX;JR|UxRTBwOUW0OlEh|ryPM{jYbHNCVkeHUh?=
J82MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV\JR|UxRTBwOUW1OFMh|ryPMkjEV2FPT0WU
KE-37MnTvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXPxcm9GUUN3ME2wMlk3Ozh5IN88US=>MYHTRW5ITVJ?
NOMO-1MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX\OeoRXUUN3ME2wMlk3PTZ2IN88US=>MoD2V2FPT0WU
ML-2NHX5dHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWLD[XVJUUN3ME2wMlk6PzVizszNMknuV2FPT0WU
SW872MlTkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4TKRmlEPTB;MD65PVc4PSEQvF2=M4nuWnNCVkeHUh?=
KYSE-520Ml:zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkfrTWM2OD1zLkCwOFk1KM7:TR?=NH71dVFUSU6JRWK=
HL-60MoHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkP3TWM2OD1zLkCwPVch|ryPM{nSZXNCVkeHUh?=
HDLM-2NE\aVIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWXPUG1mUUN3ME2xMlAyOjV{IN88US=>M{CzWHNCVkeHUh?=
MIA-PaCa-2MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M135OmlEPTB;MT6wNVM4PSEQvF2=M3vzN3NCVkeHUh?=
TCCSUPM3rSN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoXITWM2OD1zLkCxO|MzKM7:TR?=M1vCfnNCVkeHUh?=
SH-4MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4D4RmlEPTB;MT6wNlI1PCEQvF2=MV;TRW5ITVJ?
MG-63M3nBbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFnjOZZKSzVyPUGuNFI3OTZizszNM1fxPHNCVkeHUh?=
NB6NEfUOJVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVTJR|UxRTFwMEOxNFkh|ryPNUT3VJVzW0GQR1XS
CAL-54NIrmVWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYX5NINNUUN3ME2xMlA{QTV7IN88US=>NEHlO2xUSU6JRWK=
DU-145MnTHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIXx[JVKSzVyPUGuNFgxPzNizszNM2nCOXNCVkeHUh?=
HCE-4MnuxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYPq[FlLUUN3ME2xMlA6Ojh4IN88US=>NYrnXJoyW0GQR1XS
U-266MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFPHSplKSzVyPUGuNFk3OzNizszNM1jhOHNCVkeHUh?=
HT-1197Moe3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWrTZoV{UUN3ME2xMlEyPDN6IN88US=>NInMZmVUSU6JRWK=
EW-1M1G3TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUOzVWFuUUN3ME2xMlE1OTJ6IN88US=>NHH6[4lUSU6JRWK=
MHH-NB-11NUf4N25IT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4\RU2lEPTB;MT6xOVM3QCEQvF2=MUfTRW5ITVJ?
NCI-H2405NITRc|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFHuRnFKSzVyPUGuNVYyPiEQvF2=MUXTRW5ITVJ?
COLO-668NELJT2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVTJR|UxRTFwMU[0PUDPxE1?NVXzfpI2W0GQR1XS
IMR-5M3WyNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWLJR|UxRTFwMU[5N|Yh|ryPNWnCXHZbW0GQR1XS
ARH-77NXO2UlNJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYn6VphRUUN3ME2xMlIzQTJ2IN88US=>MoTJV2FPT0WU
BHT-101MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWXJR|UxRTFwMkO0PUDPxE1?Mm[0V2FPT0WU
SCC-25MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnXnTWM2OD1zLkKzOVM3KM7:TR?=MWjTRW5ITVJ?
NTERA-S-cl-D1MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnewTWM2OD1zLkK0N|Q3KM7:TR?=NV;vTplVW0GQR1XS
MKN28NGnLZWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTFwMkW2N|Yh|ryPNH\BZ3BUSU6JRWK=
KS-1MkjRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4\qNWlEPTB;MT6yPFI3QSEQvF2=NFPrNXJUSU6JRWK=
NCI-H1734MnzOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHLVI1KSzVyPUGuNlg6OTNizszNNUfiPWNvW0GQR1XS
ES7NXW2eoxuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIS3Sm5KSzVyPUGuNlk2PDJizszNM3PPUHNCVkeHUh?=
NCI-H838MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn\VTWM2OD1zLkOwOlE2KM7:TR?=M3zPRXNCVkeHUh?=
HEC-1NW[yUYQzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYf2WHJlUUN3ME2xMlM{PzV3IN88US=>NFvve|FUSU6JRWK=
ME-180NF61WY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mor4TWM2OD1zLkO3PVk{KM7:TR?=NHfnVZJUSU6JRWK=
MMAC-SFMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEm5emNKSzVyPUGuN|k2QTVizszNNFnLZXZUSU6JRWK=
IA-LMMn;CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml;kTWM2OD1zLkSwPVE1KM7:TR?=NYG2eYl[W0GQR1XS
MN-60NIruXWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUTGTpo6UUN3ME2xMlQ{OTF2IN88US=>MVPTRW5ITVJ?
SIMANHr3VWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mnf3TWM2OD1zLkS4Olg4KM7:TR?=MV3TRW5ITVJ?
NCI-H1770NH\l[3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4rLSWlEPTB;MT61NlA2PCEQvF2=MXPTRW5ITVJ?
ONS-76M{\S[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH34W5FKSzVyPUGuOVI{OTFizszNMY\TRW5ITVJ?
LB771-HNCNUjkS|N1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTFwNUO5NFYh|ryPM1f6bnNCVkeHUh?=
SW48NUK5e3hyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4W0XGlEPTB;MT61OFI1OyEQvF2=NVTpOmpSW0GQR1XS
KYSE-140NUDyNnpST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFnaW2xKSzVyPUGuOVU4PDFizszNNVvm[nZuW0GQR1XS
SW626MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkXUTWM2OD1zLkW4NVYh|ryPMVfTRW5ITVJ?
MC-CARNYfUelZvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MljwTWM2OD1zLkW4OlY{KM7:TR?=M1rsdHNCVkeHUh?=
D-336MGM3;hbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MljlTWM2OD1zLk[yPVQh|ryPM3O4V3NCVkeHUh?=
SK-MEL-3NH7hXWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVXJR|UxRTFwNkO5NFIh|ryPNIXzd|dUSU6JRWK=
MHH-PREB-1MknrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIW0UoRKSzVyPUGuOlQ1PzNizszNM2LEN3NCVkeHUh?=
Calu-1M1TPO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4XlV2lEPTB;MT62OVM5PiEQvF2=NFv1bJdUSU6JRWK=
HCC1806Mo\WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1GyPGlEPTB;MT62OlYyOSEQvF2=NVjwVVJ[W0GQR1XS
A101DMm\SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnPmTWM2OD1zLk[2O|gyKM7:TR?=NVn0eYlXW0GQR1XS
A704M2O5XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTFwNkizNVEh|ryPMkX0V2FPT0WU
LB831-BLCNFHMSFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXr2ZoxqUUN3ME2xMlY6QDV2IN88US=>M13teHNCVkeHUh?=
RL95-2MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF7M[pFKSzVyPUGuO|E1PjNizszNM4HaPXNCVkeHUh?=
RPMI-2650MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlXzTWM2OD1zLkeyO|E6KM7:TR?=NHT5O2NUSU6JRWK=
NH-12MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWjJRYJsUUN3ME2xMlc{PDJ5IN88US=>M4fIXnNCVkeHUh?=
AGSNWTYPVRCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXTjOHliUUN3ME2xMlc3OzV6IN88US=>M1fpXHNCVkeHUh?=
NEC8M3;xZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml3jTWM2OD1zLke4PVk2KM7:TR?=NFL3OIhUSU6JRWK=
NCI-H2009M4HDV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnXxTWM2OD1zLke5O|IyKM7:TR?=NEi5cpZUSU6JRWK=
A498MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn[5TWM2OD1zLkixNlgzKM7:TR?=M1LofnNCVkeHUh?=
NCI-H810M{TPcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkDuTWM2OD1zLkixOlA3KM7:TR?=MXTTRW5ITVJ?
SK-NEP-1MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVTJR|UxRTFwOEO3Olch|ryPM3PC[nNCVkeHUh?=
D-542MGMoq5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGPKclRKSzVyPUGuPFU5PTFizszNNGnLRYNUSU6JRWK=
KNS-42MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVXtU2lNUUN3ME2xMlg3OjZ4IN88US=>MXjTRW5ITVJ?
NCI-H2452MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3q5bmlEPTB;MT64PVA4PCEQvF2=MVzTRW5ITVJ?
SK-MEL-2MlvRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NG\PVJpKSzVyPUGuPVAzPzFizszNMl7XV2FPT0WU
OVCAR-5MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXLacZBUUUN3ME2xMlkxPjd3IN88US=>NHzac5hUSU6JRWK=
SNG-MMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1\oOGlEPTB;MT65OVg2QCEQvF2=NVTLcJpmW0GQR1XS
A673NYn1R3ZvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYTTPIRZUUN3ME2xMlk4PTF4IN88US=>MWrTRW5ITVJ?
L-428MlvmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3\NVWlEPTB;MT65PVE4QSEQvF2=NVv4e5c5W0GQR1XS
KM-H2MnPvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYLJR|UxRTJwMEGwPUDPxE1?MkLsV2FPT0WU
MC-IXCMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4fWeGlEPTB;Mj6wNlI4OyEQvF2=M1PSSnNCVkeHUh?=
COLO-678NV\adYp[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXv0W|EzUUN3ME2yMlA1OjB5IN88US=>NFj6VldUSU6JRWK=
MEL-JUSONYLvcVQ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXvJR|UxRTJwMEe4OVEh|ryPMYDTRW5ITVJ?
HCC38MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF;qXWJKSzVyPUKuNFg1OzNizszNNIC4U4ZUSU6JRWK=
UACC-62NF7yZYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULVWW1kUUN3ME2yMlA5QDV3IN88US=>NFPCUG9USU6JRWK=
OAW-42NUPKTJBbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV;aUIdPUUN3ME2yMlA6PzFzIN88US=>MVnTRW5ITVJ?
LB996-RCCMWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnLCTWM2OD1{LkGzPFE4KM7:TR?=M3vBU3NCVkeHUh?=
COR-L105M{Xmb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWLrTJk1UUN3ME2yMlE3Ozd|IN88US=>MVHTRW5ITVJ?
RCC10RGBNV7FOVQ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIr4RohKSzVyPUKuNVg2PzZizszNMkLYV2FPT0WU
A431MlS5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV3JR|UxRTJwMUmwNVkh|ryPNH3PUmpUSU6JRWK=
NCI-H292M1nuNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M13v[GlEPTB;Mj6yN|k2OSEQvF2=MUPTRW5ITVJ?
SK-UT-1M3LSSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWDFeXhsUUN3ME2yMlM{OTh2IN88US=>MUPTRW5ITVJ?
PANC-08-13NESwOVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3TqNmlEPTB;Mj6zN|I{PSEQvF2=M2ro[3NCVkeHUh?=
ST486NI[5em1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1rvcmlEPTB;Mj60NVA1QCEQvF2=Mn2wV2FPT0WU
SJSA-1MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV;JR|UxRTJwNEGyO|Eh|ryPNVTrZWt2W0GQR1XS
RKOMX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVjJR|UxRTJwNEKwNlkh|ryPNXriXWttW0GQR1XS
NCI-H1793MlrMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVfpbY5PUUN3ME2yMlQ1ODJ7IN88US=>NUjPSZJiW0GQR1XS
639-VNXLxXVJuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWTJR|UxRTJwNEWzPFIh|ryPMUHTRW5ITVJ?
ES3NGfleZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHLs[FZKSzVyPUKuOFk4OzdizszNMmPzV2FPT0WU
NCI-H1792M1XHRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1rDOWlEPTB;Mj61OlgzPiEQvF2=NYLPUJlzW0GQR1XS
NCI-H1651M1q0cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mlj3TWM2OD1{LkW4NlEh|ryPMXHTRW5ITVJ?
SN12CM2rZZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mlj1TWM2OD1{LkW4OFg4KM7:TR?=NEj6OINUSU6JRWK=
COLO-679M4nOdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXfJR|UxRTJwNUi2NFUh|ryPMUPTRW5ITVJ?
U-118-MGNUDJfHBzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF7zT4ZKSzVyPUKuOVg5PzJizszNNUX4[|d[W0GQR1XS
Ramos-2G6-4C10M4nqcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGOyN49KSzVyPUKuOlQ5ODdizszNMXLTRW5ITVJ?
HCT-15NEfF[3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVzJR|UxRTJwNki3PVIh|ryPMUnTRW5ITVJ?
MDA-MB-157MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF6zWGFKSzVyPUKuO|A4PDdizszNMYjTRW5ITVJ?
K5MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWj6WYFHUUN3ME2yMlcyQDR3IN88US=>NFjxXWtUSU6JRWK=
MKN45M{PQT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmXJTWM2OD1{LkezN|Y3KM7:TR?=NHrSTXNUSU6JRWK=
DMS-273MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHH5dm1KSzVyPUKuO|U3OzJizszNM4LQbXNCVkeHUh?=
C8166MlfmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUfJR|UxRTJwN{i1NVMh|ryPM2DlbXNCVkeHUh?=
Calu-3MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGPHS2dKSzVyPUKuO|g6PjlizszNM4nLPXNCVkeHUh?=
SNB75NID3b21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXnJR|UxRTJwOEi1N|Uh|ryPMkXmV2FPT0WU
BFTC-905M4\0TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmHVTWM2OD1{LkmwNVkyKM7:TR?=NV\xOmI4W0GQR1XS
C-4-IIM3\zSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYXEVZNqUUN3ME2yMlkyOzV|IN88US=>NVrHcII1W0GQR1XS
MS-1NYr3TlJXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkPqTWM2OD1{Lkm2O|Y6KM7:TR?=NFvRRWFUSU6JRWK=
A375NVK1fXBzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIXxTppKSzVyPUOuNFgyQDRizszNNITBWm9USU6JRWK=
KYSE-70MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2r0TGlEPTB;Mz6wPFg5OiEQvF2=NUTQblQ4W0GQR1XS
KYSE-510Mk\iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlXVTWM2OD1|LkGwPVk2KM7:TR?=NGDZfoNUSU6JRWK=
LN-405M3zWTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWPJR|UxRTNwMUO1NVgh|ryPMYnTRW5ITVJ?
BOKUMYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXrJR|UxRTNwMUSyOVYh|ryPNH7tZYFUSU6JRWK=
TE-10NYfUVXUzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUPJR|UxRTNwMUezOlIh|ryPNInwOpZUSU6JRWK=
MKN1Mm\ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4LWcWlEPTB;Mz6xPFQ5OyEQvF2=NIH6UFNUSU6JRWK=
M059JM2\Ze2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTNwMkCxO|Mh|ryPMX7TRW5ITVJ?
GOTOM4LrfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXrhN4tUUUN3ME2zMlIzODN7IN88US=>NYLwemNpW0GQR1XS
DK-MGMWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYDJR|UxRTNwMkW5O|Yh|ryPMWjTRW5ITVJ?
NCI-H727NVPmTpZYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVfJR|UxRTNwMk[1PEDPxE1?NX;o[GlYW0GQR1XS
NB12NFrCVZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4\zcWlEPTB;Mz6zN|IzPCEQvF2=M{nsTHNCVkeHUh?=
DOKNV3Xc3JsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mnz6TWM2OD1|LkO2NVg3KM7:TR?=NH7QNWVUSU6JRWK=
KYSE-410NUHqOYFVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXnpSZRHUUN3ME2zMlM3Ojh5IN88US=>NIK4bY9USU6JRWK=
AM-38MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M33F[GlEPTB;Mz6zPFA2OSEQvF2=M3z0S3NCVkeHUh?=
GR-STM1HCc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXjJR|UxRTNwNEW3N|Ih|ryPNIHyT2JUSU6JRWK=
D-247MGMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzLSG5lUUN3ME2zMlQ5OjZ|IN88US=>MnTFV2FPT0WU
TE-8M1jiZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVLmc5hDUUN3ME2zMlQ6OzN|IN88US=>NVKxfJhWW0GQR1XS
LS-411NMXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2TkXWlEPTB;Mz60PVY6OiEQvF2=M2\3e3NCVkeHUh?=
SK-MES-1M2D4d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2fNdmlEPTB;Mz61OlQ{OyEQvF2=MkXiV2FPT0WU
SF295NXTBOmljT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYHJR|UxRTNwNkG1OVIh|ryPMlrxV2FPT0WU
SK-MEL-30MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M33KSGlEPTB;Mz62OVkzOSEQvF2=NUm0WGRTW0GQR1XS
LB2241-RCCMlz3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGDycY5KSzVyPUOuOlYzPiEQvF2=MX;TRW5ITVJ?
PC-14NEPzcnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkjPTWM2OD1|Lk[2OFM4KM7:TR?=Ml3LV2FPT0WU
EW-7M3nxUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXrJR|UxRTNwNke2PVMh|ryPNHXiOHdUSU6JRWK=
NMC-G1M1;XVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mlj4TWM2OD1|LkexPFM4KM7:TR?=NIjIdpVUSU6JRWK=
TE-441-TMlHhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH[4VHlKSzVyPUOuO|MxOjhizszNMVnTRW5ITVJ?
NCI-H1618NV;1VFZFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUDJR|UxRTNwOEG4O|Uh|ryPM2TsXHNCVkeHUh?=
PANC-03-27NFnn[nhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmX6TWM2OD1|LkixPVE3KM7:TR?=MY\TRW5ITVJ?
NCI-H2228MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml;BTWM2OD1|LkizNVI3KM7:TR?=M4nUUHNCVkeHUh?=
CAPAN-1M3TFXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2POSGlEPTB;Mz64O|AxQSEQvF2=MlrPV2FPT0WU
KLEMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGTzPFZKSzVyPUOuPVA3PyEQvF2=M4\6WnNCVkeHUh?=
BeckerM4nlcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M37aSWlEPTB;Mz65Nlg1QSEQvF2=M{joU3NCVkeHUh?=
SK-PN-DWMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3\1XmlEPTB;ND6wO|k4PCEQvF2=MX;TRW5ITVJ?
Hs-578-TNHr1cZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2rvRWlEPTB;ND6wPFMxPiEQvF2=MkOzV2FPT0WU
RS4-11NIfafG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn36TWM2OD12LkGxNlU2KM7:TR?=MoTCV2FPT0WU
D-502MGMmTKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{[xO2lEPTB;ND6xOlk6PyEQvF2=NF\R[WhUSU6JRWK=
GI-1M4LhdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXyTWM2OD12LkK4Nlk6KM7:TR?=M{G1d3NCVkeHUh?=
NCI-H209MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU\ROnh2UUN3ME20MlM{PzhizszNNXrLW5pJW0GQR1XS
SK-OV-3NHf0NZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3y1d2lEPTB;ND60PFE1QSEQvF2=NIf3NpNUSU6JRWK=
LOUCYM1fj[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWfNfGNHUUN3ME20MlQ5PDN{IN88US=>NYj4UVNCW0GQR1XS
NCI-H69M3:4[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUXJR|UxRTRwNUG3PVMh|ryPNXjtWo1PW0GQR1XS
SCC-9MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmHjTWM2OD12LkWzNVczKM7:TR?=NWjZc2NjW0GQR1XS
NCI-H526M{XFTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MY\JR|UxRTRwNUmyPVMh|ryPMm[5V2FPT0WU
NCI-H2170Mn;LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH3RU|NKSzVyPUSuOlY4PzFizszNMojiV2FPT0WU
SRNXXmNHBLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFXDT2NKSzVyPUSuO|AxPDhizszNMnnFV2FPT0WU
CMKM2joVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NU\sTJBtUUN3ME20MlczOTBzIN88US=>NYHPd4VnW0GQR1XS
COLO-829NGDlSFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnPWTWM2OD12Lke3NFQ{KM7:TR?=M1[5N3NCVkeHUh?=
HuO-3N1NFfLTmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUnJR|UxRTRwOEOyPFEh|ryPNH3zRXpUSU6JRWK=
5637MoHlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUPq[I9qUUN3ME20MlkxPDh5IN88US=>NYTQSFIzW0GQR1XS
A253MnPnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXHJR|UxRTRwOUe3NFgh|ryPNF\SdpFUSU6JRWK=
NB10M2TuWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVjJR|UxRTVwMEe0PVch|ryPMXzTRW5ITVJ?
SF539MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX7JR|UxRTVwMEm5OVkh|ryPMWfTRW5ITVJ?
HAL-01NE\nVIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFH0cmNKSzVyPUWuNVQ3PDVizszNM{KzOXNCVkeHUh?=
MHH-ES-1MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmLPTWM2OD13LkG2PVI2KM7:TR?=NWHa[YZiW0GQR1XS
DELMkCxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVnJR|UxRTVwMke1PFIh|ryPM{PxbnNCVkeHUh?=
NCI-H1299M2T4dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{TxfmlEPTB;NT6zOVAxPyEQvF2=NUe2clN7W0GQR1XS
ChaGo-K-1M4rGO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFPudI5KSzVyPUWuN|UyODdizszNNFrNS5ZUSU6JRWK=
HMV-IIMVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVjHbXlNUUN3ME21MlM6PDNizszNMVLTRW5ITVJ?
NB69NFHjTVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnPETWM2OD13LkO5OlMyKM7:TR?=MX;TRW5ITVJ?
NCI-H1882NVu2TVJOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoPuTWM2OD13LkSzN|Y1KM7:TR?=NVrnRYFjW0GQR1XS
SNU-475M{[4RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{nRSWlEPTB;NT60O|E4OSEQvF2=NWTDZngzW0GQR1XS
RXF393NIrXNHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4XmdGlEPTB;NT60PFQ6PCEQvF2=MWTTRW5ITVJ?
CAL-51NUP3fJpmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M17vdmlEPTB;NT62Nlg2OyEQvF2=M2\hbHNCVkeHUh?=
SW1573MkjJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4P4cWlEPTB;NT62N|U{PCEQvF2=NIfXZlBUSU6JRWK=
GCTMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYjJR|UxRTVwN{W5Nlkh|ryPMUXTRW5ITVJ?
COR-L88MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYTYUVBbUUN3ME21Mlc3QDR4IN88US=>M3fNTXNCVkeHUh?=
MDA-MB-134-VINF7mbI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXTJR|UxRTVwOEe1N|Yh|ryPMX;TRW5ITVJ?
NB5NUX2W49tT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXXJR|UxRTVwOUK0OEDPxE1?NET1OoVUSU6JRWK=
GMS-10MkTrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVTJR|UxRTVwOU[4OlEh|ryPMkC2V2FPT0WU
CHP-212MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3;oWWlEPTB;Nj60PFI3PyEQvF2=M3LBXnNCVkeHUh?=
TE-11M1nrc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWrJR|UxRTZwNUWxPFIh|ryPMnjlV2FPT0WU
SW962NYnl[JhHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWnJR|UxRTZwNkW3O|Qh|ryPMkmwV2FPT0WU
MZ2-MELNEfoZXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3O3TWlEPTB;Nj64NlAyOSEQvF2=MknyV2FPT0WU
C-33-AMonnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX\WNY1YUUN3ME22MlkyPjh6IN88US=>NYnSfpRoW0GQR1XS
IGR-1MnK1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDmbYVMUUN3ME22Mlk4QDJ4IN88US=>NYG2[oE1W0GQR1XS
MOLT-4M2DCVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnPaTWM2OD15LkG1OFA3KM7:TR?=NUPnbpg5W0GQR1XS
NCI-H1650MoexS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEnGNIdKSzVyPUeuNlcxPDZizszNNIXNTplUSU6JRWK=
AsPC-1MknuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoLMTWM2OD15LkK4OlA2KM7:TR?=NEHNVnhUSU6JRWK=
SNU-C2BMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoXhTWM2OD15LkK5OVcyKM7:TR?=MlPqV2FPT0WU
MKN7NUjE[XdnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2nMNGlEPTB;Nz6zO|I{PSEQvF2=NEnNb4JUSU6JRWK=
SW620MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV;JR|UxRTdwM{iyNFUh|ryPMoLaV2FPT0WU
SK-MEL-28Ml;zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYHJR|UxRTdwNEC3PVgh|ryPMUTTRW5ITVJ?
TE-6M3Xofmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTdwNES5NFgh|ryPMUTTRW5ITVJ?
D-263MGM2XrPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTdwNEW3OlIh|ryPNEnmN|hUSU6JRWK=
NCI-H1355MoOxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1K0OWlEPTB;Nz63O|AzQSEQvF2=MmXXV2FPT0WU
DSH1M4jKbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M171c2lEPTB;Nz63PVc3OiEQvF2=NXrNUo9QW0GQR1XS
NCI-H460NXfmOVRWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{nNdGlEPTB;OD6wNFY6PCEQvF2=MoDNV2FPT0WU
NCI-H1563NYHMNlJ6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWrBW|N3UUN3ME24MlA4PTB6IN88US=>NFrn[IRUSU6JRWK=
SW948M{DTemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlnyTWM2OD16LkGwO|Q1KM7:TR?=NGSybVVUSU6JRWK=
LK-2NUjNfFdnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH\wRllKSzVyPUiuNVI5OzNizszNNYTlXVJbW0GQR1XS
HT-1080NWewNZh[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NETtbXJKSzVyPUiuNVMyPzVizszNMYDTRW5ITVJ?
NCI-H441NV7udpd{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1LVOWlEPTB;OD6xPVMh|ryPMlTFV2FPT0WU
HSC-4MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUXJR|UxRThwMki3NkDPxE1?MYfTRW5ITVJ?
LXF-289MkfCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHuxNWVKSzVyPUiuN|U6PDNizszNMU\TRW5ITVJ?
MRK-nu-1MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYPteFNIUUN3ME24MlM3OzB2IN88US=>NHH5enVUSU6JRWK=
no-11M3Pwbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH\0dnpKSzVyPUiuOFcyOzNizszNM{fwUXNCVkeHUh?=
SNU-387NGfaUFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF[2bHlKSzVyPUiuOlMzPDZizszNM2jhW3NCVkeHUh?=
Detroit562MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NITORmdKSzVyPUiuO|U1PTVizszNMX3TRW5ITVJ?
SW954M1zidGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWr4S4lGUUN3ME24Mlc3QDN{IN88US=>M4rVUHNCVkeHUh?=
P12-ICHIKAWANH\6dZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlPKTWM2OD16Lke4PVQh|ryPM3m1OXNCVkeHUh?=
TE-9MoXIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFS3e2xKSzVyPUiuPFExPjJizszNMlT6V2FPT0WU
NB13NGHYflRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mnf3TWM2OD16LkizO|k3KM7:TR?=NXW0emNmW0GQR1XS
BPH-1NXG2VI1wT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX6yWlY5UUN3ME24Mlg2ODhzIN88US=>NVXhc|lLW0GQR1XS
KMOE-2M3v3PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYTJR|UxRThwOEe4PVIh|ryPMYfTRW5ITVJ?
RPMI-8402MoL1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVTIXmFNUUN3ME24Mlg6QTJ4IN88US=>NFrmSY1USU6JRWK=
OVCAR-3NWnkbVRXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Moe2TWM2OD16Lkm3O|MzKM7:TR?=M2fWSHNCVkeHUh?=
NCI-H2196M2DS[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\BdmlEPTB;OD65PFYxPiEQvF2=M17ufnNCVkeHUh?=
MZ7-melNVrNbGYyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXvOOmpGUUN3ME25MlA{PDZizszNMmnUV2FPT0WU
GP5dMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkPqTWM2OD17LkC2N|E{KM7:TR?=M17MdHNCVkeHUh?=
NCI-N87MmHRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MULJR|UxRTlwNES3N|Eh|ryPMnS3V2FPT0WU
EW-16M4Lwc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{PiWWlEPTB;OT60OFg1QCEQvF2=MkLsV2FPT0WU
Calu-6NYrjbVRmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXr4XpZ5UUN3ME25MlQ6PzB|IN88US=>NUjNSIlMW0GQR1XS
LC4-1NVSw[IZST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX3SNnl2UUN3ME25MlYzPTdizszNM1i4c3NCVkeHUh?=
CCRF-CEMM1;hZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW\xeJdTUUN3ME25MlY5PzZ4IN88US=>M{XyeXNCVkeHUh?=
BC-1MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3P0fGlEPTB;OT63PFk6KM7:TR?=NYPwR3d1W0GQR1XS
NCI-SNU-16M2e2VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M135cmlEPTB;OT63PVQ6PSEQvF2=NF\4[WtUSU6JRWK=
NCI-H28NIP0PJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NY\wT4pXUUN3ME25Mlg1QTN|IN88US=>MX3TRW5ITVJ?
SBC-1MmL3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFfoRo9KSzVyPUGwMlA4OiEQvF2=M{n2Z3NCVkeHUh?=
TURMmi5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NE[zZYhKSzVyPUGwMlE3PTdizszNMXrTRW5ITVJ?
MDA-MB-231MoG0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlfPTWM2OD1zMD6yNVE1KM7:TR?=MYfTRW5ITVJ?
C3AMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M333OGlEPTB;MUCuN|E4QSEQvF2=M2G5XXNCVkeHUh?=
SW1990MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX3JR|UxRTFyLkOyPEDPxE1?M1XsOnNCVkeHUh?=
NCI-H1993NV:3VWhMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkOyTWM2OD1zMD61Olk{KM7:TR?=NYrnZmhHW0GQR1XS
SK-CO-1MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXnWVYpwUUN3ME2xNE44PzdizszNNYDtXJd6W0GQR1XS
OAW-28MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGfiSnZKSzVyPUGwMlk5QDhizszNNV;C[Ho6W0GQR1XS
HNMWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU\3N3RUUUN3ME2xNU4yOTNzIN88US=>MkXVV2FPT0WU
NCI-H1304M13rTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXeyWYVDUUN3ME2xNU4yPTd4IN88US=>MVHTRW5ITVJ?
DaoyNYj1[2VzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUHJR|UxRTFzLkSzN|Yh|ryPNVHzNnBLW0GQR1XS
VA-ES-BJMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEPKPZRKSzVyPUGxMlcyQTVizszNNVSw[I17W0GQR1XS
MCF7M4XQXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2HISmlEPTB;MUGuPFEzPiEQvF2=NX;4V4JMW0GQR1XS
VM-CUB-1MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUHNbnBvUUN3ME2xNU46ODlzIN88US=>NF3GW2lUSU6JRWK=
IPC-298MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX:yT2RvUUN3ME2xNU46Ozh|IN88US=>NEXZTXJUSU6JRWK=
NCI-H2126M13OOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH7lZYRKSzVyPUGyMlAzOThizszNMojmV2FPT0WU
OVCAR-8NWOwcFVOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYnJR|UxRTF{LkGxOFEh|ryPNViyPZN4W0GQR1XS
SJRH30MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTF{LkKyPVkh|ryPNXTWVFRWW0GQR1XS
DMS-53NGO4dZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYDOdWZQUUN3ME2xNk4zPjR7IN88US=>MVjTRW5ITVJ?
NCI-H322MNXfMR2w5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXYTWM2OD1zMj6zN|U4KM7:TR?=MWPTRW5ITVJ?
RVH-421MnTNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF;yVW9KSzVyPUGyMlQ6ODRizszNNHqwO4tUSU6JRWK=
RajiMk\RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUHJR|UxRTF{Lk[xOEDPxE1?NWXRZ2NIW0GQR1XS
MDA-MB-415NVy3O2NKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYPJR|UxRTF{Lk[0OFQh|ryPMlPxV2FPT0WU
EFE-184MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEDhOVlKSzVyPUGyMlcyODZizszNNGPoNJpUSU6JRWK=
BFTC-909Mkj3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVPJR|UxRTF{LkmyOFch|ryPMnzQV2FPT0WU
BHYMnLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUHJR|UxRTF|LkOzPUDPxE1?NUHVdmREW0GQR1XS
YKG-1MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGHVUZlKSzVyPUGzMlM4PDlizszNMkHYV2FPT0WU
EW-3NXHlUYxyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGr6TYJKSzVyPUGzMlcyPjNizszNNWTpcZdQW0GQR1XS
HCC1143MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEn6T4dKSzVyPUGzMlc1OzdizszNNGXTSWFUSU6JRWK=
REHMmXNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmXaTWM2OD1zMz64PVgzKM7:TR?=M3[zXHNCVkeHUh?=
CESSNWCzZnFWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXexeJo6UUN3ME2xN{46PDh7IN88US=>NEPZRW5USU6JRWK=
EFM-19NYnhWlJST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYXzUHZrUUN3ME2xOE4yOTF{IN88US=>M3TCZXNCVkeHUh?=
U031MofaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Moe2TWM2OD1zND60NFg2KM7:TR?=Moe1V2FPT0WU
ES1NF\xUZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{e5[WlEPTB;MUSuOFg2OSEQvF2=M3PBOHNCVkeHUh?=
HSC-3NWjM[FdpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV:wT45YUUN3ME2xOE43OjF3IN88US=>MYLTRW5ITVJ?
LOXIMVIMnT2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mnu1TWM2OD1zND63NFY5KM7:TR?=NXTaOWxoW0GQR1XS
A388MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1zuOWlEPTB;MUSuO|U2PiEQvF2=M3TwUXNCVkeHUh?=
KP-N-YSMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHLX[2FKSzVyPUG0Mlc4OyEQvF2=NY[3dWlrW0GQR1XS
Capan-2NVjvcWpHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXfJR|UxRTF2Lke4OkDPxE1?MYXTRW5ITVJ?
SKG-IIIaMWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIr2dXFKSzVyPUG0Mlg5PjJizszNMlHoV2FPT0WU
HELNV3MNpNKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUTJR|UxRTF2Lki5PVch|ryPM{XWNnNCVkeHUh?=
BENM2LmeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWfJR|UxRTF2Lkm3OlYh|ryPM{XvOnNCVkeHUh?=
MC116M131dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlfVTWM2OD1zNT6xOVk6KM7:TR?=NIjDe3hUSU6JRWK=
IGROV-1MkLlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoPsTWM2OD1zNT6yN|E4KM7:TR?=MmjyV2FPT0WU
NCI-H1648Mne1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWPIcG11UUN3ME2xOU42OzB3IN88US=>NHm0No5USU6JRWK=
ABC-1NVjFeVQ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUPyNGlwUUN3ME2xOU45ODN|IN88US=>MlftV2FPT0WU
EW-18NXXTeoNQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVTk[pZ{UUN3ME2xOU46QTd7IN88US=>MlrhV2FPT0WU
BC-3Mn3GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV71dlh7UUN3ME2xOk4xPTZ{IN88US=>NIHGO4FUSU6JRWK=
NCI-H1437MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1XxcGlEPTB;MU[uNFY3PyEQvF2=MUnTRW5ITVJ?
SCC-15MoLQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFvQTlFKSzVyPUG2MlI5OjVizszNNU[wOGtVW0GQR1XS
TTNXHnR5pRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXHJR|UxRTF4LkW4PFgh|ryPNXLL[5hPW0GQR1XS
KINGS-1MnPJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXrJR|UxRTF4LkiyO|Mh|ryPMV;TRW5ITVJ?
C32MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4[yR2lEPTB;MU[uPVcyPyEQvF2=MWjTRW5ITVJ?
SBC-5MmnKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXz3WoFGUUN3ME2xO{4yPDd7IN88US=>NEDUNWNUSU6JRWK=
NB1MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mm\DTWM2OD1zNz6zNVg5KM7:TR?=NHfKTXlUSU6JRWK=
EB-3NWrrOWhIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4XENWlEPTB;MUeuOVc3KM7:TR?=MXXTRW5ITVJ?
NCI-H748NIHrXHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGrNVI5KSzVyPUG3MlcxOzVizszNM1TxNnNCVkeHUh?=
IST-SL1NVLZbJBbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXTJR|UxRTF5Lke1NlYh|ryPMUXTRW5ITVJ?
WM-115NG\p[4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml72TWM2OD1zNz64NFg2KM7:TR?=NXXzS5RLW0GQR1XS
NCI-H226NGjTN|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2LMXmlEPTB;MUeuPVU1PiEQvF2=MXLTRW5ITVJ?
CAL-33NX[zVnF7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYLYeHJrUUN3ME2xPE4zPzhzIN88US=>MWfTRW5ITVJ?
SCC-4NGX3WoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1\mXGlEPTB;MUiuN|IzQSEQvF2=MnexV2FPT0WU
RMG-IM4r0Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1;4e2lEPTB;MUiuOlk1PyEQvF2=M{DKWXNCVkeHUh?=
KOSC-2NEXBOpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkfmTWM2OD1zOD63O|Q3KM7:TR?=M1nPOXNCVkeHUh?=
A2058NV;GRYR7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFXLfZVKSzVyPUG4MlgzPTVizszNMYnTRW5ITVJ?
HCC70MlzmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHLZXXVKSzVyPUG5MlM5QTRizszNNHXnb5RUSU6JRWK=
C2BBe1Mn;sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV3JR|UxRTF7LkSxOFgh|ryPM121c3NCVkeHUh?=
NCI-H650Mnr4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rUN2lEPTB;MUmuOVg6QSEQvF2=NXznXY5kW0GQR1XS
CAL-72M4flNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1TUOWlEPTB;MUmuOlc{PyEQvF2=NYizflVYW0GQR1XS
L-363MkPrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XxdWlEPTB;MkCuNFIyOiEQvF2=NUHhcIpWW0GQR1XS
SNU-423MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3HPcGlEPTB;MkCuNVA1OyEQvF2=NYC1NHFFW0GQR1XS
PLC-PRF-5NHLwPVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkjNTWM2OD1{MD6zPVA3KM7:TR?=NEnWXnFUSU6JRWK=
SW1463M4\Oc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXrJR|UxRTJyLkS1NlUh|ryPNULydo1{W0GQR1XS
769-PMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV3JR|UxRTJyLk[3Olkh|ryPNF;WR4hUSU6JRWK=
DMS-79NVzUeVJFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3zaR2lEPTB;MkCuPFQ6KM7:TR?=M2PQUHNCVkeHUh?=
Saos-2NFfmPZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3XXPWlEPTB;MkCuPVU2PiEQvF2=NWe0PHNlW0GQR1XS
CHP-126M4DYSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3TPcWlEPTB;MkGuOFQ3OiEQvF2=NGHRZ3ZUSU6JRWK=
SW837MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{GyNWlEPTB;MkGuOFk{QSEQvF2=NFfydVVUSU6JRWK=
SHP-77M2fU[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkjDTWM2OD1{MT62NVIzKM7:TR?=NG\KelVUSU6JRWK=
DBMn7MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml3BTWM2OD1{MT62NVQzKM7:TR?=M3qxXHNCVkeHUh?=
ES5Ml7BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDGclV5UUN3ME2yNU43QDZ2IN88US=>M4LZTHNCVkeHUh?=
COR-L23MoHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIXac3hKSzVyPUKxMlgxPTFizszNNVr6OpBQW0GQR1XS
KU-19-19NUfO[W1UT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV7JR|UxRTJzLki5PFIh|ryPM4DkZnNCVkeHUh?=
T84MmLMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2PZbGlEPTB;MkGuPVgyQSEQvF2=NULMemQ5W0GQR1XS
NCI-H630Mo[xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWjKfXBNUUN3ME2yNk42OzZ|IN88US=>MkPEV2FPT0WU
LU-165MmPUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVLFZ|VqUUN3ME2yNk42PTRizszNMl7XV2FPT0WU
COLO-792NI\zNmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkLKTWM2OD1{Mj63NVEyKM7:TR?=MmPUV2FPT0WU
CAL-62MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2\6NWlEPTB;MkKuO|UyPyEQvF2=NV\iVmdsW0GQR1XS
HCE-TMVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYXJR|UxRTJ{Lki2NFYh|ryPMkDnV2FPT0WU
BB65-RCCMknQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlXCTWM2OD1{Mz6wN|Q1KM7:TR?=M365bXNCVkeHUh?=
SiHaM1nHNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoHCTWM2OD1{Mz6zPVY5KM7:TR?=M2TrfXNCVkeHUh?=
NCI-H2081MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkfGTWM2OD1{ND6wOlQyKM7:TR?=MUTTRW5ITVJ?
U251NYHscmFJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4DRXGlEPTB;MkSuNFY3QCEQvF2=Mn2xV2FPT0WU
LoVoNXvjXXdUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mnf0TWM2OD1{ND65NlgzKM7:TR?=M3G1[3NCVkeHUh?=
GCIYMXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{TiS2lEPTB;MkWuNlg4PyEQvF2=M{jWSHNCVkeHUh?=
NUGC-3MnrkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHTmXGJKSzVyPUK1MlM{OTZizszNMWXTRW5ITVJ?
LNCaP-Clone-FGCM1jPUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXf5fFBjUUN3ME2yOU4{PDl6IN88US=>NWfSZY97W0GQR1XS
PA-1NVTENHV4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWftTIpPUUN3ME2yOU43QDN|IN88US=>MkLtV2FPT0WU
OE33MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3[1OGlEPTB;MkWuOlg2OyEQvF2=NVLKT2k1W0GQR1XS
HT-29MoH1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1qxNWlEPTB;MkWuO|g4QSEQvF2=NGnTdHJUSU6JRWK=
RCM-1NVX5[JFET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWHJR|UxRTJ3Lkm2OVYh|ryPMorFV2FPT0WU
NCI-H1522NIHiSJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGPsOYhKSzVyPUK1Mlk6OTFizszNNVjsXnhpW0GQR1XS
LB373-MEL-DMV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVnJR|UxRTJ4LkG3NFgh|ryPM1fYPXNCVkeHUh?=
NCI-H1436MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVOwfGJtUUN3ME2yOk4zPzN6IN88US=>MnvKV2FPT0WU
COLO-824M3HJdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXjFU|EyUUN3ME2yOk41ODB{IN88US=>NG\QenZUSU6JRWK=
CP50-MEL-BNGSyRWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml2xTWM2OD1{Nj61Olc2KM7:TR?=NX;2THllW0GQR1XS
EGI-1NX20[3IzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUTJR|UxRTJ5LkK2PVgh|ryPM{[zdnNCVkeHUh?=
LAN-6MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3TmbGlEPTB;MkeuN|U6QCEQvF2=MV3TRW5ITVJ?
GAKNHvHZ2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4jrNmlEPTB;MkeuOFIzPSEQvF2=NYDoemtFW0GQR1XS
MDA-MB-175-VIIM{XVdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEnY[mhKSzVyPUK3MlUxPTNizszNMni3V2FPT0WU
JVM-2MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWToN|U5UUN3ME2yO{43PjJ{IN88US=>M3nhPXNCVkeHUh?=
UACC-257Ml;US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoDoTWM2OD1{Nz62PFc5KM7:TR?=NV7WZpdJW0GQR1XS
SW1783MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYjJR|UxRTJ5Lke3PFMh|ryPNF3RbHdUSU6JRWK=
HT-3NGDBWIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1\ZZWlEPTB;MkiuNlE3PiEQvF2=Mn;vV2FPT0WU
RLNFT3[WZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M172NGlEPTB;MkiuOVkyOSEQvF2=NUeyc3N[W0GQR1XS
TK10NVG5Z|lwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkXzTWM2OD1{OD62OVM2KM7:TR?=MknIV2FPT0WU
HT55MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX;1T4FNUUN3ME2yPU4xPTZ3IN88US=>MlW0V2FPT0WU
BT-20NGnjWItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXnJR|UxRTJ7LkC1PFYh|ryPMl3OV2FPT0WU
TGBC24TKBMWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1;mfWlEPTB;MkmuNVg{OSEQvF2=M4fsT3NCVkeHUh?=
HSC-2MnXJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXKyZ4lRUUN3ME2yPU4{ODBzIN88US=>NEXkXVVUSU6JRWK=
COLO-205NHnkeYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4fhV2lEPTB;MkmuN|k1PCEQvF2=MXPTRW5ITVJ?
GT3TKBNHXNe3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYnJR|UxRTJ7Lk[4O|ch|ryPNUjpbotlW0GQR1XS
T47DMoPoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnvnTWM2OD1{OT64OVgzKM7:TR?=NHHC[IFUSU6JRWK=
OMC-1MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYLJR|UxRTNyLkG5NVkh|ryPNF7pcZFUSU6JRWK=
PFSK-1NYnrdFVoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkXkTWM2OD1|MT6yOlU6KM7:TR?=M{D2WHNCVkeHUh?=
JEG-3NV3kRpVbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlPBTWM2OD1|MT6zOVYyKM7:TR?=M3vBc3NCVkeHUh?=
RDNVuzUmNKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXPMOJJnUUN3ME2zNU42OTF3IN88US=>MWjTRW5ITVJ?
NCI-H64MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH;rfXZKSzVyPUOyMlQyPzlizszNNYrMR|FwW0GQR1XS
DMS-114M1XGVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWHJR|UxRTN{LkSxPFIh|ryPMmf1V2FPT0WU
NCI-H661MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1fD[2lEPTB;M{KuOlUxOSEQvF2=MmHXV2FPT0WU
CAL-148Mn\rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUC3[GVEUUN3ME2zNk43PjZ3IN88US=>MWPTRW5ITVJ?
HuP-T3NXnrb5dsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{DvVGlEPTB;M{KuPVM{QCEQvF2=NVL6OoVoW0GQR1XS
ES4MlfZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWXJR|UxRTN|LkG3NFUh|ryPMoXrV2FPT0WU
Ca9-22NGK0VVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn7HTWM2OD1|Mz60OlAyKM7:TR?=NUj2SYhsW0GQR1XS
LP-1MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXTJR|UxRTN2LkC5JO69VQ>?NX7ibWpmW0GQR1XS
AU565M4LicGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEDzbo1KSzVyPUO0MlUxPjlizszNMonyV2FPT0WU
MDA-MB-453NULJ[odkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX;sNZFYUUN3ME2zOU4yPDJ4IN88US=>Ml7OV2FPT0WU
SNU-C1NXvlcFdKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV3lfHRHUUN3ME2zOU4yPzFizszNMV;TRW5ITVJ?
SW13NUXJV5BvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWqxSmRGUUN3ME2zOU41ODd4IN88US=>MVXTRW5ITVJ?
NCI-H2122MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV33eZVbUUN3ME2zOU42PTl6IN88US=>NXnm[|NWW0GQR1XS
NCI-H1395M37Yc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmTkTWM2OD1|NT62OlkyKM7:TR?=M3vVTnNCVkeHUh?=
J-RT3-T3-5MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{TSR2lEPTB;M{[uNFI6PCEQvF2=MnzaV2FPT0WU
COR-L279NUS0NFZPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M136TmlEPTB;M{[uNVk5OSEQvF2=NX\teXM{W0GQR1XS
ATN-1NGT4N3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTN4Lki1NVYh|ryPNEO2UW5USU6JRWK=
HCC2998MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHrFXJBKSzVyPUO2Mlg2PzFizszNMonxV2FPT0WU
UM-UC-3Mo\jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIC0cI1KSzVyPUO2Mlg3PzVizszNMXLTRW5ITVJ?
DV-90MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NE[3fIRKSzVyPUO2MlkxPjdizszNMknMV2FPT0WU
ES8NEHOV|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYr6PVlZUUN3ME2zOk46OzF6IN88US=>NF;GdJFUSU6JRWK=
YAPCM3KyUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4HNZWlEPTB;M{[uPVY2PCEQvF2=NWi1NWlHW0GQR1XS
HCC1599NEHsPFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3rodmlEPTB;M{euNVYyQCEQvF2=MUXTRW5ITVJ?
UMC-11NXnKVWtET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYTTc2UxUUN3ME2zO{4zPTB|IN88US=>MojQV2FPT0WU
THP-1NVXtVGlHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlzNTWM2OD1|Nz6yPFY5KM7:TR?=NWPUWIlGW0GQR1XS
OCUB-MMnfoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV;JR|UxRTN5LkK4PVEh|ryPMXvTRW5ITVJ?
NCI-H1693M1;2[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{O0bmlEPTB;M{euN|I{OyEQvF2=NIexcVJUSU6JRWK=
NCI-H345NXi4XVBjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUPzOJhHUUN3ME2zO{4{PjJ2IN88US=>MkfSV2FPT0WU
COLO-800MmHTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV70RYIxUUN3ME2zO{42PjdizszNMULTRW5ITVJ?
COLO-320-HSRMnrXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGTvXZFKSzVyPUO4MlM1QTJizszNM3\CcXNCVkeHUh?=
NCI-H596M1LYZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYTnWZlRUUN3ME2zPE41PDh7IN88US=>MU\TRW5ITVJ?
NCI-H187M3;FOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHfTfmNKSzVyPUO4Mlc{PDRizszNMYjTRW5ITVJ?
ECC4M{PPdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn\JTWM2OD1|OT6wPFE1KM7:TR?=NIPkeXRUSU6JRWK=
KP-4Mm\iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYTJR|UxRTN7LkGyN|Uh|ryPMYDTRW5ITVJ?
NCI-H2227NGXKZYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3rwbGlEPTB;M{muN|k1QSEQvF2=M4n3fnNCVkeHUh?=
22RV1MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1u0cWlEPTB;M{muPFM6QCEQvF2=M2judXNCVkeHUh?=
SASNYi0UWl5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUD6SIJHUUN3ME20NE4xQTZizszNMlHkV2FPT0WU
PANC-10-05NX7OS|BET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV\ie2sxUUN3ME20NE4yQDJ6IN88US=>M4\TSnNCVkeHUh?=
MDA-MB-468MmrzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1fLeGlEPTB;NECuOVM1PiEQvF2=NEPoRVVUSU6JRWK=
RPMI-7951NGTRNWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnnYTWM2OD12MT6yNFc2KM7:TR?=MV\TRW5ITVJ?
BB49-HNCMY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NELkPIFKSzVyPUSxMlIyPzlizszNM1OzfnNCVkeHUh?=
23132-87M2[w[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYTJR|UxRTRzLkK3N|Ih|ryPM{j1ZXNCVkeHUh?=
HCC1569MljNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NW\hNYo2UUN3ME20NU4zQDh3IN88US=>NXq2[Jc4W0GQR1XS
CP66-MELNVLtbpF{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1LGdmlEPTB;NEKuNVg5PiEQvF2=M4PkWHNCVkeHUh?=
K-562MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUDJR|UxRTR{LkK4OVQh|ryPNH3pd2xUSU6JRWK=
OCI-AML2M2TBOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUTJR|UxRTR{Lki5O|Qh|ryPNGXoXo9USU6JRWK=
SW756NXPWcGtNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWTBPGlpUUN3ME20N{4xOzh6IN88US=>M1\PcHNCVkeHUh?=
M14MonPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUTJR|UxRTR|LkOxPFkh|ryPMmrWV2FPT0WU
NCI-H1623NHi5cGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlriTWM2OD12Mz60OlQh|ryPMlHiV2FPT0WU
KNS-81-FDMWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH3CRpZKSzVyPUSzMlc3OiEQvF2=M3fNdnNCVkeHUh?=
TGBC1TKBNWTBRo5KT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXHFVFFFUUN3ME20N{46ODl7IN88US=>NWTUUWZMW0GQR1XS
RERF-LC-MSMnvnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVnJR|UxRTR|LkmyPFEh|ryPNEHhZZFUSU6JRWK=
PC-3NHXqVZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXrJR|UxRTR2LkSzOFch|ryPNInlU2lUSU6JRWK=
HuP-T4NGe2PJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkTiTWM2OD12ND60OFc1KM7:TR?=M{X3SHNCVkeHUh?=
NCI-H510AMkTaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmLpTWM2OD12ND63NFgh|ryPNHvMT4JUSU6JRWK=
LB2518-MELMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHe0XIFKSzVyPUS0Mlc6OzdizszNNH3rc|hUSU6JRWK=
TE-5NEnPfIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUDWTVhuUUN3ME20OU46PThzIN88US=>Mn3uV2FPT0WU
EW-24M3vVSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnP1TWM2OD12Nj6xO|I{KM7:TR?=NV3McGcyW0GQR1XS
LB647-SCLCMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlTOTWM2OD12Nj6yNVU2KM7:TR?=MY\TRW5ITVJ?
NCI-H524NHnDTm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlTmTWM2OD12Nj63NVg2KM7:TR?=NF7DdHVUSU6JRWK=
EW-11MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mk\STWM2OD12Nj65N|c{KM7:TR?=NVXEWWVFW0GQR1XS
KALS-1MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYTqNVI{UUN3ME20O{4zODZ4IN88US=>M4LSWXNCVkeHUh?=
BT-474NXHQNmZDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYfyRXdCUUN3ME20O{41OjF4IN88US=>NFezeoZUSU6JRWK=
SK-N-ASNYXB[XZvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV;JfHZnUUN3ME20O{45QDhizszNNIjxWFJUSU6JRWK=
HCC2157MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4XrNmlEPTB;NEiuNFc3KM7:TR?=NFzPU4RUSU6JRWK=
HCC1954MmPDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVrmdXBCUUN3ME20PE4yPzB2IN88US=>MoDjV2FPT0WU
FADUNX[0bFRNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWLJR|UxRTR6LkOwN|Eh|ryPMl[xV2FPT0WU
S-117NWrhZ2ZbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYfJR|UxRTR6LkO4NVUh|ryPMUnTRW5ITVJ?
LS-1034MmS2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFH6ZYdKSzVyPUS4MlcxPjdizszNNF7MWJJUSU6JRWK=
CAMA-1MnLQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXTJR|UxRTR7LkW1OFMh|ryPNV25NVdUW0GQR1XS
LU-134-AMonzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV7nd|JvUUN3ME20PU45ODh3IN88US=>M37TdnNCVkeHUh?=
NCI-H1838MkSyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnTlTWM2OD12OT64NFg4KM7:TR?=NX\vNJhoW0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo In a mouse xenograft model of Ba/F3 cells expressing native Bcr-Abl, AP24534 (2.5 mg/kg and 5 mg/kg) prolongs mice median survival. In the xenograft model of Ba/F3 Bcr-AblT315I, AP24534 (10 mg/kg–50 mg/kg) significantly suppresses tumor growth. AP24534 (30 mg/kg) decreases the phosphorylated Bcr-Abl and phosphorylated CrkL levels in the tumors. [2]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

Peptide substrate phosphorylation assays with GST-Abl kinase domains The effect of AP24534 (0-320 nM) on GST-Abl kinase activity is assessed by using a synthetic peptide substrate (Abltide: EAIYAAPFAKKK). Assays are carried out at 30 °C for 15 min in 25 μL reaction mixture: 8 mM MOPS (pH 7), 0.2 mM EDTA, 50 μM Abltide, 30 mM MgCl2, 10 mM β-glycerol phosphate, 1 mM EGTA, 0.002% Brij-35, 0.4 mM DTT, 0.2 mg/mL BSA, 0.4 mM sodium orthovanadate, 10 nM WT or mutant GST-Abl kinase, and 100 µM ATP/γ-32[P]ATP (5000 cpm/pmol). Reactions are terminated by transferring a portion of the reaction mixture onto a p81 phosphocellulose filter and immersing in 0.75% phosphoric acid. Filters are washed 3 times in 0.75% phosphoric acid, rinsed in acetone, and air dried; phosphate incorporation is determined by scintillation counting. All results are corrected for background binding to the filters, as determined by omitting peptide substrate from the kinase reaction. Time course experiments to establish the linear range of enzymatic activity precedes kinase assays.

Cell Assay: [2]

Cell lines Ba/F3 cells expressing Bcr-Abl or a range of single mutations in the kinase domain of Bcr-Abl
Concentrations 0-625 nM
Incubation Time 72 hours
Method Ba/F3 cell lines are distributed in 96-well plates (4 × 103 cells/well) and incubated with AP24534 for 72 hours. Proliferation is measured using a methanethiosulfonate (MTS)-based viability assay (CellTiter96 Aqueous One Solution). All values are normalized to the control wells with no drug. IC50 values are reported as the mean of three independent experiments performed in quadruplicat

Animal Study: [1]

Animal Models Mouse xenograft models of Ba/F3 cells expressing Bcr-Abl or Bcr-AblT315I
Formulation Dissolved in 25 mM citrate buffer, pH 2.75
Dosages 2.5 mg/kg and 5 mg/kg for Ba/F3 Bcr-Abl; 2.5 mg/kg–50 mg/kg for Ba/F3 Bcr-AblT315I
Administration Oral gavage once daily

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] O'Hare T, et al. Cancer Cell, 2009, 16(5), 401-412.

[2] Huang WS, et al. J Med Chem, 2010, 53(12), 4701-4719.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-04-16)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT01888562 Withdrawn Endometrial Neoplasms Washington University School of Medicine January 2016 --
NCT02627677 Recruiting Chronic Phase Chronic Myeloid Leukemia Ariad Pharmaceuticals December 2015 Phase 3
NCT02398825 Not yet recruiting Chronic Myeloid Leukemia|Chronic Phase|Adults Gruppo Italiano Malattie EMatologiche dellAdulto December 2015 Phase 2
NCT02478164 Recruiting Glioblastoma Dana-Farber Cancer Institute July 2015 Phase 2
NCT02448095 Not yet recruiting Chronic Myeloid Leukemia|Philadelphia Positive Gruppo Italiano Malattie EMatologiche dellAdulto July 2015 --

view more

Chemical Information

Download Ponatinib (AP24534) SDF
Molecular Weight (MW) 532.56
Formula

C29H27F3N6O

CAS No. 943319-70-8
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 30 mg/mL (56.33 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 30% PEG400/0.5% Tween80/5% propylene glycol 10 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 3-(2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide

Customer Product Validation (2)


Click to enlarge
Rating
Source Cancer Cell 2012 22(5), 656-667 . Ponatinib (AP24534) purchased from Selleck
Method Western blot
Cell Lines RCH-ACV cells
Concentrations 50 nM
Incubation Time 1-24 h
Results Treatment of these cells with a CSK inhibitor (BMS-599626) or a BTK inhibitor (PCI-32765) did not recapitulate the dasatinib/ponatinib phenotype.

Click to enlarge
Rating
Source Genome Biol, 2014, 15(8): 428 . Ponatinib (AP24534) purchased from Selleck
Method Cell Proliferation Assay
Cell Lines KatoIII cells
Concentrations 0-0.5 nM
Incubation Time
Results Each of the inhibitors demonstrated a statistically significant lower IC50 in FGFR2-amplified KatoIII cells compared to non-FGFR2-amplified AGS cells at all concentrations tested.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Bcr-Abl Products

  • PX-478 2HCl

    PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-1α) inhibitor. Phase 1.

  • Defactinib (VS-6063, PF-04554878)

    Defactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.

  • SU6656

    SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.

  • Imatinib Mesylate (STI571)

    Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM in cell-free or cell-based assays, respectively.

  • Nilotinib (AMN-107)

    Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM in Murine myeloid progenitor cells.

    Features:A selective inhibitor of native and mutant Bcr-Abl.

  • Bafetinib (INNO-406)

    Bafetinib (INNO-406) is a potent and selective dual Bcr-Abl/Lyn inhibitor with IC50 of 5.8 nM/19 nM in cell-free assays, does not inhibit the phosphorylation of the T315I mutant and is less potent to PDGFR and c-Kit. Phase 2.

    Features:Dual Bcr-Abl/Lyn inhibitor.

  • Degrasyn (WP1130)

    Degrasyn (WP1130) is a selective deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor and also suppresses Bcr/Abl, also a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT).

    Features:WP1130 has an advantage over imatinib mesylate in that its activity is not inhibited by a variety of Abl kinase mutations, including T315I.

  • DCC-2036 (Rebastinib)

    DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

    Features:A conformational control inhibitor of Abl1 and T315I Abl1.

  • GZD824 Dimesylate

    GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

  • GNF-2

    GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no activity to Flt3-ITD, Tel-PDGFR, TPR-MET and Tel-JAK1 transformed tumor cells.

Recently Viewed Items

Tags: buy Ponatinib (AP24534) | Ponatinib (AP24534) ic50 | Ponatinib (AP24534) price | Ponatinib (AP24534) cost | Ponatinib (AP24534) solubility dmso | Ponatinib (AP24534) purchase | Ponatinib (AP24534) manufacturer | Ponatinib (AP24534) research buy | Ponatinib (AP24534) order | Ponatinib (AP24534) mouse | Ponatinib (AP24534) chemical structure | Ponatinib (AP24534) mw | Ponatinib (AP24534) molecular weight | Ponatinib (AP24534) datasheet | Ponatinib (AP24534) supplier | Ponatinib (AP24534) in vitro | Ponatinib (AP24534) cell line | Ponatinib (AP24534) concentration | Ponatinib (AP24534) nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us